An Early-Stage Study in Multiple Clinics of How Afimkibart May Affect the Body's Processing of Medicines That Rely on Cytochrome P450 Enzymes in Participants With Ulcerative Colitis
Clinical trial NCT07665723 · RECRUITING
Trial details
- NCT number
- NCT07665723
- Sponsor
- Hoffmann-La Roche
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-29
- Primary completion
- 2027-07-31
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.